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Abstract
Background: Previous reports about laparoscopic total pelvic exenteration (LTPE) are still limited. In the present
study, we described our single-center experience of the initial 11 cases.
Methods: Between April 2011 and September 2015, eight males and three females diagnosed as pelvic malignancies
underwent LTPE by the same operation team. We retrospectively collected all cases’ parameters about surgical
technique. Thirty-seven patients who received open surgery were also retrospectively collected. A comparison
between LTPE and open surgery was performed to evaluate the feasibility and safety of LTPE.
Results: Eleven cases successfully underwent the LTPE without any intraoperative complication. No open conversion
was required. Eight patients underwent Bricker’s procedure. Three patients were performed with the cutaneous
ureterostomy. Anus preservation operation was performed in three patients. Compared with open surgery, LTPE had
longer mean operative time (565.2 vs 468.2 min, p = 0.004) but less mean blood loss (547.3 vs 1033.0 ml, p < 0.001) and
shorter postoperative hospitalization time (15.3 vs 22.4 days, p = 0.004). One patient died of pulmonary embolism in
the 7th month of follow-up time. One patient died of recurrence in the 12th month of follow-up time. Nine patients
are still alive without recurrence and metastasis. The mean follow-up time was 11.1 months.
Conclusions: The technique of LTPE seems to be feasible and safe in the treatment of carefully selected patients of
pelvic malignancies. LTPE can also decrease the blood loss, the recovery time, and the hospital stay. But the
oncological safety and long-term outcome of LTPE still need to be explored.
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Background
Total pelvic exenteration (TPE) is a surgical procedure
that refers to a radical resection of the rectum, bladder,
and reproductive organs. In 1948, it was first described
by Brunschwig [1] as a palliative way for the terminal
stages of the advanced pelvic malignancies. Classical
open TPE has a high rate of postoperative morbidity but
a relatively low mortality [2]. The open procedure is
nowadays mainly used in the treatment of pelvic
malignancies, such as locally advanced, recurrent cervical
and colorectal cancer. It improves the long-term survival
of patients with primary advanced rectal cancer [2].
In 2003, Pomel reported the first case of the laparoscopic
total pelvic exenteration (LTPE) to treat the cervical cancer
relapse [3]. From then, the LTPE was successively per-
formed by some experienced laparoscopic centers. A
cohort study has proved that the laparoscopic procedure is
feasible and curative to selected patients [4]. From 2011,
we began to carry out LTPE in our hospital by multidiscip-
linary cooperation.
We have searched for almost all literature about LTPE
in the past decade. The articles about this procedure are
still limited. In this study, we introduced our experience
of LTPE with the initial eleven cases’ results.
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Methods
Eight males and three females were diagnosed as pelvic
malignancies by biopsy and were selected to receive
LTPE from April 2011 to September 2015. The selected
criteria included the following: preoperative pathological
diagnosis of pelvic malignancies (e.g., colorectal cancer,
cervical cancer, or prostate cancer.), no evidence of
distant metastasis, the possibility of complete resection,
no surgical contraindication, and sufficient understand-
ing about this procedure’s risk by the patient. The sur-
gery was performed by the same surgical team. All cases’
demographic data, preoperative parameters (see Table 1),
surgical parameters, and follow-up information about
LTPE were retrospectively collected. The study was
approved by the institutional review board from Peking
University First Hospital.
The following criteria for preoperative preparation
were listed:
1. All patients had confirmed diagnosis with a preoperative
biopsy.
2. Ultrasonography, enhanced computerized tomography
scan or magnetic resonance imaging of the abdomen
and pelvis, should be done to stage the disease and
determine the extent of the tumor (see Fig. 2a–d, the
bladder was invaded by tumor).
3. Preoperative standard bowel preparation in no ileus
patient.
4. Evaluation of the physical condition to exclude any
preoperative contraindication.
5. Informed contents were accepted and signed off by
all patients and their family members.
To evaluate the efficiency and safety of LTPE, we also
retrospectively collected the surgical parameters of 37
patients who received classical TPE from 2011 to 2015
to perform a comparison between LTPE and open
surgery. The classical TPE needed a longitudinal incision
(at least 15 cm) on the abdominal midline.
Surgical technique
Epidural anesthesia was applied in combination with
general anesthesia. All patients were equipped with
patient-controlled analgesia after surgery.
After anesthesia, patient was placed in Lloyd-Davis
position. Pneumoperitoneum was established by open
technique from the umbilicus. The positions of ports were
modified from the Puntambekar’s way [5] (see Fig. 1a). A
Trendelenburg (30°) position and right lateral tilt (30°)
were maintained during the dissection of the sigmoid and
rectum.
The procedure began with the dissection of posterior
wall and lateral walls of the rectum. The right lateral
peritoneum of the rectosigmoid was incised with the
Harmonic Ace (Ethicon Endo-Surgery, Inc., Cincinnati,
OH) by the middle enter approach. After entering to the
posterior space of the rectosigmoid, the dissection was
continued until to the root of inferior mesenteric artery.
The inferior mesenteric vessels were ligated and cut.
The left lateral peritoneum was also incised to meet with
right lateral peritoneum. The retrorectal space was dis-
sected to the level of levator ani muscle, and the lateral
walls of the rectum were freed.
The tissues around the bladder and the ureter were
dissected. Then, the bladder and the ureter were exposed.
Table 1 Patient demographics and preoperative parameters
Patient no. Gender Age BMI Preoperative diagnosis Preoperative complications nCRT ASA
1 Male 57 25.3 Bladder transitional cell carcinoma (grade 3)
and rectal adenocarcinoma
Lower gastrointestinal bleeding No 2
2 Male 62 23.5 Prostate sarcoma (recurrent) Difficult defecation No 2
3 Male 58 19.9 Sigmoid adenocarcinoma (bladder invasion) Rectovesical fistula Colonic obstruction No 2
4 Male 62 23.3 Rectal adenocarcinoma (bladder invasion) Rectovesical fistula No 2
5 Male 75 25.9 Bladder transitional cell carcinoma (grade 2)
and rectal adenocarcinoma
Acute renal insufficiency Hypertension No 2
6 Female 69 21.7 Sigmoid adenocarcinoma (bladder and
uterus invasion)
Hypertension No 2
7 Female 55 23.4 Sigmoid adenocarcinoma (bladder invasion) Rectovesical fistula No 2
8 Male 44 24.7 Rectal adenocarcinoma (bladder invasion) Renal calculi No 2
9 Female 65 22.3 Sigmoid adenocarcinoma (bladder invasion) Diabetes mellitus No 2
10 Male 71 25.1 Sigmoid adenocarcinoma (bladder invasion) Benign prostatic hyperplasia colonic
obstruction
No 2




nCRT neoadjuvant chemoradiotherapy, ASA American Standards Association, BMI body mass index
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Seminiferous duct and superior vesical artery were bound
with Hem-o-lok and cut with Harmonic Ace (Ethicon
Endo-Surgery, Inc., Cincinnati, OH), following the bladder,
lateral ligaments were cut with a Ligasure (Ligasure Vessel
Sealing System: Valleylab, a division of Tyco Healthcare
Group LP, Boulder, CO). The dissection should not be
stopped until reaching the level of levator ani muscle. The
urachus was cut off and the cave of Retzius was entered.
The puboprostatic ligament was cut. After the dorsal vein
complex was ligated and cut, the urethra and the ureter
were cut with Harmonic Ace (Ethicon Endo-Surgery, Inc.,
Cincinnati, OH). The sigmoid was cut with the Endo-GIA.
Anus was sutured, and a new fusiform incision around
the anus was performed. Ischiorectal fossa was dissected
to the level of levator ani muscle. The specimen was
removed (see Fig. 2e–h), and the fusiform incision was
Fig. 1 Trocar distribution and the situation of the stoma. a Trocar distribution; b the ileal bladder stoma and the sigmoid stoma of case 3;
c the ileal bladder stoma of case 4 (the surgical scar is relatively small)
Fig. 2 The computerized tomography (CT) image before surgery and surgical specimens of case 3 and case 4. a, b CT image of case 3, c, d CT
image of case 4; the red arrows show the bladders are invaded by tumor; the white arrows show the air bubbles in the bladder because of
rectovesical fistula; e, f the specimen of case 3, g, h the specimen of case 4 (the black arrows show the same results to the radiographic results)
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sutured. Further surgery needed a 4-cm vertical umbilical
incision to perform the urinary diversion (like Bricker’s
operation, cutaneous ureterostomy) and sigmoidostomy
(see Fig. 1c).
If the patient was suitable for anus preservation oper-
ation, the operation was performed till the urethra and
the ureter were cut according to the above steps. Then,
the anterior rectal wall was exposed. After mesorectum
was dissected, the rectum was cut with the Endo-GIA at
about 5 cm away to the inferior margin of the tumor. A
4-cm vertical umbilical incision was performed. The
bladder and rectal tumor was brought out from the inci-
sion, and the sigmoid was cut at about 10 cm away to
the superior margin of the tumor. A string suture was
performed at the end of the colon, and the anvil of a circu-
lar stapler was placed into it. The Bricker’s operation or
cutaneous ureterostomy could be completed from the
vertical incision (see Fig. 1b, c). Pneumoperitoneum was
rebuilt after the incision was closed. At last, the head of the
stapler was introduced from the anus into the distal stump.
A colorectal anastomosis was successfully performed.
All patients routinely received the pelvic lymphadenectomy.
Postoperative management
The drain was removed depending on the drainage
volume. The stomas should be kept flowing well. The
patients diagnosed with metastatic lymph nodes by the
pathological examination all received the adjuvant
chemotherapy.
Results
Surgery was successfully performed in all patients. Eight
patients underwent Bricker’s procedure after the bladder
was resected. The cutaneous ureterostomy was performed
in case 2, case 10, and case 11. Anus preservation oper-
ation was performed in case 4, case 7, and case 9. The
details about operation parameters were shown in Table 2.
The comparison between LTPE and open surgery was
shown in Table 3. We could find that there were no
differences in gender and age between two groups. But it
was quite clear that LTPE had longer mean operative time
(565.2 vs 468.2 min, p = 0.004), less mean blood loss
(547.3 vs 1033.0 min, p < 0.001), and shorter mean postop-
erative hospitalization time (15.3 vs 22.4 days, p = 0.004).
The mean follow-up time was 11.1 months. Case 1
died of pulmonary embolism in the 7th month of
follow-up time. Case 2 died of oncological recurrence
and metastasis in the 12th month of follow-up time.
Case 3 to case 11 were still alive without indication of
recurrence and metastasis when followed up. Case 11
suffered from ileus after surgery. After conservative
treatment, the ileus was relieved without surgical inter-
vention. Five patients received adjuvant chemotherapy of
XELOX regiment (Oxaliplatin, 130 mg/m2, IV over 2 h,
day 1 plus capecitabine, 850–1000 mg/m2, twice daily,
PO, for 14 days; repeat every 3 weeks) 3 weeks after
hospital discharge.
Discussion
TPE has become a major surgical technique widely used
for curative resection of locally advanced or recurrent
pelvic malignancies since the 1940s. The classical TPE is
open surgery which has a high rate of postoperative
complication but relatively low surgical mortality. With
the improvement of surgical techniques, the overall
major morbidity rate after TPE is still up to 75 % (13 to
75 %) in previous literature [6–9], but the mortality has
decreased from rates up to 33 % [10–14] down to rates
less than 10 % (0 to 10 %) [15–17].
The emergence of laparoscopic surgery is an important
milestone of the modern surgery. This revolution means
the arrival of the minimal invasive surgery. Compared
with open procedure, less intraoperative blood loss, less
postoperative pain, and shorter hospital stay are the
outstanding advantages of the laparoscopic procedure.
Previously, the oncological outcome of the laparoscopic
surgery was not acceptable, and the resection of the tu-
mors was considered incomplete due to its small operative
space. But in a randomized trail of 209 cases of colonic
adenocarcinoma, the results showed that laparoscopy-
assisted colectomy was more effective than open colec-
tomy for treatment of colon cancer in terms of morbidity,
hospital stay, tumor recurrence, and cancer-related sur-
vival [18]. Many other published studies have also proved
the oncological safety of laparoscopic procedure [19–22].
With the advancement of technology and surgical skills,
the laparoscopy is now widely used in the treatment of
gynecological, colonic, and prostatic cancer.
In 2003, Pomel et al. reported the first case of LTPE
with a cervical cancer relapse and showed the feasibility
and safety of the procedure [3]. Subsequently, Lin et al.
reported a case of laparoscopy-assisted transvaginal TPE
[23]. In 2009, a robotic-assisted TPE was first reported
by Peter in USA [24]. In 2011, an entirely robotic total
pelvic exenteration and extended lymphadenectomy for
recurrent endometrial cancer was reported by Vasilescu
et al. [25]. Among the published literature, we found that
22 cases of different kinds of pelvic malignancies under-
went LTPE in several oncological institutions around the
world in the last decade (see Table 4) [3, 5, 23–31]. At
present, there is still no large sample report about the
long-term outcome of LTPE.
Previous reports show that mean operative time of
LTPE is ranging from 230 up to 831 min, and mean
postoperative hospitalization stay varies from 3.5 to
29 days. In our series, mean operative time and mean
hospital stay are similar to others, respectively 565.2 min
and 15.3 days. But both parameters are much shorter in
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Table 2 Operative parameters and follow-up results

















1 Yes Bricker’s procedure and
sigmoidostomy
(Miles procedure)
620 500 Rectum pT2N0M0 and
Bladder pT2bN0M0
Negative 23 No DVT (7 months) 7 No Died of
non-oncological
disease (PE)
2 Yes Cutaneous ureterostomy
and sigmoidostomy
(Miles procedure)
415 600 Prostate pT4N0M0 Negative 10 No UTI (6 months) 12 No Died of
oncological
recurrence
3 Yes Bricker’s procedure and
sigmoidostomy
(Hartmann procedure)
574 420 Sigmoid pT3 N1M0 Negative 15 No No 24 XELOX Alive
4 Yes Bricker’s procedure and anus
preservation operation
616 650 Rectum pT4b N1M0 Negative 11 No No 22 XELOX Alive
5 Yes Bricker’s procedure and
sigmoidostomy
(Hartmann procedure)
690 800 Rectum pT3N0M0
Bladder pT1N0M0
Negative 26 No No 14 No Alive
6 Yes Bricker’s procedure and
sigmoidostomy
(Hartmann procedure)
660 400 Sigmoid pT4b N1M0 Negative 14 No No 14 XELOX Alive
7 Yes Bricker’s procedure and anus
preservation operation
515 600 Sigmoid pT4b N0M0 Negative 9 No No 10 XELOX Alive
8 Yes Bricker’s procedure and
sigmoidostomy
(Miles procedure)
520 850 Rectum pT4b N0M0 Negative 16 No No 7 No Alive
9 Yes Bricker’s procedure and anus
preservation operation
610 400 Sigmoid pT4b N0M0 Negative 13 No No 5 No Alive
10 Yes Cutaneous ureterostomy
and sigmoidostomy
(Hartmann procedure)
450 200 Sigmoid pT4b N1M0 Negative 11 No UTI 5 No Alive
11 Yes Cutaneous ureterostomy
and sigmoidostomy
(Miles procedure)
547 600 Rectum pT4b N1M0 Negative 20 Ileus Ileus 2 XELOX Alive
Mean 565.2 547.3 15.3 11.1













Indian study than other studies. It may be the result of
different surgical techniques and different health policies.
In addition, all the cases were female patients whose anat-
omy is relatively simple in Indian study. The hospital stay
is also closely associated with the postoperative com-
plications. The mean estimated blood loss of our
study is obviously reduced when patients underwent
laparoscopic approach, ranging from 200 to 850 ml,
compared to classical open approach, ranging from
1000 to 7550 ml [6, 32].
TPE is one of the most spoiling surgeries, requiring en
bloc resection of the pelvic organs. More than half of
the patients underwent the TPE suffered from different
kinds of major or minor complications associated with
urinary diversion and bowel reconstruction [33], especially
previous radiotherapy before surgery [34]. We hope that
the laparoscopic approach can play an important role in
reducing the morbidity rate. But dramatically, in a cohort
study, it did not work when compared to open approach
[4]. Few data were reported. More scientific studies are
still needed.
The most commonly used form of urinary diversion
(UD) for pelvic exentenration is Bricker’s ileal conduit
(IC) described first in 1950 [35]. IC has been the safest
and easiest way for urinary diversion while decreasing
the morbidity rate. The advantage of this form is to
overcome the high complication rate caused by primary
wet colostomy. Primary wet colostomy has been aban-
doned because of the 9 % high mortality rate of com-
plications [36], like electrolyte abnormalities, ascending
pyelonephritis, and malodorous watery diarrhea. In 1989,
Carter et al. [37] first described a modified wet colostomy
technique called double-barreled wet colostomy (DBWC).
In 2010, Golda et al. [38] reported their single institution
experience about DBWC drawing a conclusion that
DBWC is an alternative option for patients after TPE
when reconstruction of the fecal and urinary streams is
not possible. Compared with traditional IC, DBWC
provides a single stoma allowing for easier maintenance
and not increasing the morbidity rates. Chokshi et al. [39]
concluded the similar result with Golda’s study that
DBWC is able to provide a safe and feasible technique for
urinary and fecal diversion.
In 11 cases of our study, eight patients underwent
Bricker’s IC and three patients received cutaneous ure-
terostomy (CU). Because three patients were terminal,
CU was performed as a temporary diversion. We can
find that the operative time of case 2 and case 10 was ob-
viously much shorter than others. The procedure of CU is
simple and no need for bowel resection and anastomosis.
CU is just widely used for abdominal wall diversion in
children but rarely done in adult. The procedure is only
used for diversion in terminal stage or when bowel resec-
tion cannot be performed [40].
For fecal diversion, eight patients underwent the sigmoi-
dostomy and three patients underwent anus preservation
operation. In case 1, the distance of rectal tumor from the
anus verge was 3 cm, so a sigmoidostomy (Miles proced-
ure) was performed. But in case 4, patient received the anus
preservation operation as the distance of tumor from the
anus verge was 10 cm (>5 cm). This situation was similar
to case 7 and case 9. For case 2, case 3, case 5, case 6, and
case 10, Hartmann’s procedure was performed in consider-
ation of the possible subsequent radiotherapy or chemo-
therapy and the high risk of bowel anastomosis’ leakage.
Traditionally, open TPE is associated with high compli-
cations rates of UD and fecal diversion. Complication rate
directly related to UD after laparoscopic approach is
reported more than 50 % [4]. According to both open
approach and laparoscopic approach, the most com-
mon complication is infection, especially urinary tract
infection (UTI, 21–36 %) [4], followed by ureteral stricture
(5–22.1 %) [4], ureteral/anastomosis leaks (8–14 %) [4],
urinary stomal stricture (4–25 %) [4], and stone formation
(2–18 %) [4]. In our study, UTI occurred in two patients
(2/7, 28.6 %) more than 30 days after operation. Deep vein
thrombosis (DVT) occurred in one patient, and the pa-
tient died of pulmonary embolism; the others were well.
The patient suffered increased stool frequency at 2 months
after anus preservation operation. It was still unknown
whether LTPE can really reduce the high morbidity rates
or not. More contrast studies about morbidity rate of TPE
between open approach and laparoscopic approach need
to be done. It is proved, in this study, that the laparoscopic
approach is advantageous in decreasing the recovery time,
blood loss, and hospital stay.
Table 3 Comparison between LTPE and open surgery
LTPE Open surgery p
Gender, (male/female)/n 8/3 20/17 0.60
Median age, range/year 62 (30–75) 55 (35–80) 0.53
Mean operative time ± SD, range/minute 565.2 ± 81.4 (415–690) 468.2 ± 51.8 (360–560) 0.004
Mean blood loss ± SD, range/ml 547.3 ± 180.1 (200–850) 1033.0 ± 284.6 (670–2000) <0.001
Mean postoperative hospitalization ± SD, range/day 15.3 ± 5.3 (9–23) 22.4 ± 9.0 (10–45) 0.004
LTPE laparoscopic total pelvic exenteration, SD standard deviation
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Table 4 Previous reports of laparoscopic total pelvic exenteration
















Pomel et al. [3] 2003 1 Chemoradiotherapy 540 250 Bricker 0 0 16 NS NS NS
Lin et al. [23] 2004 1 Radiotherapy 540 200 US 0 UTI, SSI 19 12 Alive (disease free) NS
Uzan et al. [24] 2005 2 Chemoradiotherapy 510 (480–540) 525 (250–800) Bricker 0 UTI, CRAF 23.5 (17–30) 8.5 (6–11) Dead NS
Puntambekar
et al. [25]
2006 2 NS 240 200 Wet
colostomy
0 NS 3.5 15 NS NS
[5] 2009 7 NS 230 (±15) 250 (±50) Five wet
colostomy,
two Bricker







2006 3 1 NS 2 nCRT NS NS Bricker NS One Wound
dehiscence
and AMI
NS NS NS NS
Patel H et al. [27] 2009 2 Chemoradiotherapy 330 1200 Bricker 0 NS 11 NS NS NS
Lim PC [28]
(robotic-assisted)
2009 1 Chemoradiotherapy 540 1000 Bricker 0 NS 23 NS NS NS
Figueiredo
et al. [29]




Vasilescu et al. [30]
(entirely robotic)
2011 1 Radiotherapy 250 365 Cutaneous
ureterostomy
0 0 11 NS NS NS
Mukai et al. [31] 2013 1 nCRT 831 600 Cutaneous
ureterostomy
0 Ileus 29 NS NS NS
Total 22














In this study, all patients did not received the pre-
operative chemotherapy and radiotherapy. For case 3,
case 4, case 6, and case 11, because the pathologic
staging information showed positive regional lymph
nodes, XELOX regimen as postoperative chemotherapy
was recommended to patients. Case 10 refused to accept
postoperative chemotherapy. No complications-related
chemotherapy occurred. By now, no evidences of recur-
rence and metastasis have been found in these patients.
In reported literature, more than half of cases were
females who underwent the LTPE because of cervical
cancer. But in our study, only three cases were females.
Because the physiology and pelvic anatomy of the male
are different from those of the female, we do not know
whether the gender is an influencing factor to the LTPE
or not. Larger sample and gender-related analysis will be
needed in further study.
Although the oncological safety of the laparoscopic ap-
proach has been accepted in treating many oncological
diseases, the oncological safety of LTPE is still indeter-
minate as follow-up time was very limited; no series
reach 5 years of follow-up time.
We believe that the selection of patients is crucial for
a satisfactory oncological result. Patients’ compliance
and patients’ education regarding the LTPE are also im-
portant. The patient should know this surgical approach
means the obvious decrease of the quality of life. The
multidisciplinary team is an important guaranty of the
successful LTPE. Based on our experiences, at least the
urologist, the colorectal specialist and special postopera-
tive nursing group are needed.
Although in our study, the number of cases is maybe
the largest compared with previous published articles, 11
was far from enough for a persuasive study. In addition,
this was a retrospective study which was another limita-
tion. A randomized control trial will be needed in our
later work.
Conclusions
In conclusion, with the initial experience of 11 cases of
LTPE, we think that the technique of LTPE seems to be
a feasible and safe procedure in the treatment of care-
fully selected patients of pelvic malignancies. LTPE is
also advantageous in decreasing blood loss, recovery
time, and hospital stay. But the oncological safety and
long-term outcome of LTPE still need to be explored in
the future.
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images.
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